FOXO Technologies (FOXO) provides a brief shareholder letter from Seamus Lagan, recently appointed CEO of FOXO on what has been achieved in recent months and what is planned for 2025 and beyond ...

FOXO Technologies (FOXO) will hold its previously announced Special Meeting of its Shareholders at 10:30 am EST on Friday, January 17, 2025. Following the filing of its Definitive Proxy Statement ...

FOXO Technologies, Inc. ($FOXO) stock jumped about 58% on Thursday after the Minneapolis, Minnesota-based epigenetic biomarkers technology solutions company confirmed ...

FOXO Technologies, Inc. develops genetic sequencing technology, artificial intelligence and bioinformatics tools. It operates through the FOXO Labs and FOXO Life segments. The FOXO Labs segment ...

We expect these work steps will be completed in the next 30-60 days We operate three businesses; Epigenetics: FOXO Lab’s., remains a pioneer in epigenetic biomarker discovery and commercialization.

Short interest in FOXO Technologies Inc (AMEX:FOXO) decreased during the last reporting period, falling from 677.79K to 211.04K. This put 0.96% of the company's publicly available shares short.

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

FOXO Technologies, Inc. develops genetic sequencing technology, artificial intelligence and bioinformatics tools. It operates through the FOXO Labs and FOXO Life segments. The FOXO Labs segment ...